News Related to Cell and Gene Therapy Catapult

Related coverage linked through entity extraction aliases.

CGT Catapult establishes Technology Advisory Board for advanced therapy deployment

May 20, 2026

Cell and Gene Therapy Catapult has established a Technology Advisory Board to support technology deployment across advanced therapies. The board will focus on data, manufacturing, testing and patient pathways.

Review outlines non-clinical safety priorities for CRISPR-based gene therapies

May 12, 2026

A review in Genes & Diseases says robust non-clinical safety assessment is critical for CRISPR-based gene therapies. It highlights genotoxic, delivery, and immunological risks and recommends risk-based development programs.